ArticleOphthalmology science2026
Machine Learning-Based Prediction of Strabismus with and without Amblyopia from Fixation Eye Movements.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate whether machine learning (ML) models trained on fixation eye movement (FEM) features can differentiate strabismic amblyopia, strabismus without amblyopia, and visually normal controls. Design: Cross-sectional study. Participants: A total of 159 subjects were recruited from a single Cleveland Clinic site: 49 with moderate/severe strabismic amblyopia, 24 with treated/mild strabismic amblyopia, 47 with strabismus without amblyopia, and 39 controls. Methods: Fixation eye movements-horizontal and vertical eye-position traces from both eyes-were recorded during monocular viewing: fellow-eye and amblyopic-eye viewing for amblyopic subjects and right-eye and left-eye viewing for strabismic subjects without amblyopia and controls. Fixation and vergence instability, fast and slow FEM amplitude and velocity, fast-FEM frequency, and time-based eye deviation control metrics were computed using density-based clustering scans. Features were categorized as monocular, interocular within-viewing (nonviewing vs. viewing eye), interocular across-viewing (comparing the viewing eye across fellow-eye viewing vs. amblyopic-eye viewing or right-eye viewing vs. left-eye viewing), and binocular-coordination metrics (vergence instability and eye deviation measures). Six binary classification tasks were evaluated and trained using multiple ML models. Shapley Additive exPlanations (SHAP) identified the most predictive features. Main Outcome Measures: Accuracy, area under the receiver operating characteristic curve (AUROC), and SHAP-derived feature importance for each classification task. Results: Classification was strongest in distinguishing moderate/severe disease: amblyopia versus strabismus: accuracy 0.81 ± 0.09, AUROC 0.85 ± 0.09; strabismus versus controls: accuracy 0.90 ± 0.07, AUROC 0.92 ± 0.07; amblyopia versus controls: accuracy 0.90 ± 0.07, AUROC 0.97 ± 0.03. Performance was reduced for treated/mild amblyopia versus strabismus (accuracy 0.70 ± 0.12, AUROC 0.60 ± 0.19) but remained strong for treated/mild amblyopia versus controls (accuracy 0.94 ± 0.06, AUROC 0.87 ± 0.13). Classification of all amblyopia and strabismus combined versus controls achieved an accuracy of 0.89 ± 0.05 and AUROC 0.93 ± 0.04. Shapley Additive exPlanations analysis showed that abnormalities in the viewing amblyopic eye relative to the viewing fellow eye were the strongest predictors of amblyopia, whereas nonviewing-eye FEM metrics and binocular-coordination features best predicted strabismus with or without amblyopia compared with controls. Conclusions: This proof-of-concept study demonstrates that FEM-derived features combined with ML can objectively distinguish strabismic amblyopia from strabismus and controls, with strongest performance in moderate/severe disease. Future work will extend validation to younger populations and incorporate portable eye-tracking devices to support scalable, point-of-care screening. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.